Is there really room for anti-rheumatic drugs in the treatment of COVID-19?

Favalli, E G; Ingegnoli, F; Biggioggero, M; Caporali, R

Favalli, E G; Ingegnoli, F; Biggioggero, M; Caporali, R.

Favalli EG; Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute , Milan, Italy.
Ingegnoli F; Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute , Milan, Italy.
Biggioggero M; Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, University of Milan , Milan, Italy.
Caporali R; Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute , Milan, Italy.

Scand J Rheumatol ; 49(5): 412-413, 2020 09.

Article en En | MEDLINE | ID: mdl-32720847

Asunto(s)

Antirreumáticos; Infecciones por Coronavirus; Pandemias; Neumonía Viral; Adulto; Betacoronavirus; COVID-19; China; Humanos; Pacientes Internos; Estudios Retrospectivos; Factores de Riesgo; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Antirreumáticos / Pandemias Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google